LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$4.07
+0.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.81x
- Price / sales
- 44.19x
- Price / cash flow
- -1.15x
Enterprise value
- Enterprise value
- $4.6M
- EV / sales
- 23.96x
- EV / EBITDA
- -0.61x
- EV / EBIT
- -0.60x
- Market cap
- $8.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026